Vogenx (VOGX) surged 6.77% during intraday trading on Wednesday, marking a strong debut on the Nasdaq after the company priced its initial public offering.

The biotech firm priced its IPO of about 6.3 million shares at $13 each, raising gross proceeds of approximately $81.3 million. The stock began trading on the Nasdaq under the ticker symbol "VOGX," with the offering expected to close on Thursday. Underwriters have also been granted a 45-day option to purchase up to an additional 937,500 shares.

The positive first-day performance reflects investor demand for the newly issued shares above the initial offering price.